Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Augmentation of response to chemotherapy by microRNA-506 through regulation of RAD51 in serous ovarian cancers.
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
Augmentation of response to chemotherapy by microRNA-506 through regulation of RAD51 in serous ovarian cancers.
Augmentation of response to chemotherapy by microRNA-506 through regulation of RAD51 in serous ovarian cancers. J Natl Cancer Inst. 2015 Jul; 107(7).
View in:
PubMed
subject areas
Animals
Antineoplastic Combined Chemotherapy Protocols
Blotting, Western
Cell Line, Tumor
Cisplatin
Cystadenocarcinoma, Serous
DNA Damage
DNA, Neoplasm
Drug Synergism
Epithelial-Mesenchymal Transition
Female
Gene Expression Regulation, Neoplastic
HeLa Cells
Humans
Immunohistochemistry
Kaplan-Meier Estimate
Mice
Mice, Nude
MicroRNAs
Microscopy, Fluorescence
Neoplasm Transplantation
Neoplasms, Experimental
Odds Ratio
Ovarian Neoplasms
Phthalazines
Piperazines
Rad51 Recombinase
Tissue Array Analysis
Tumor Stem Cell Assay